Replaces Prod. #: ALX-550-041
Agonist at D2 and D3 dopamine receptors.
Product Details
| Formula: | C32H40BrN5O5 . CH3SO3H |
| |
| MW: | 750.7 |
| |
| CAS: | 22260-51-1 |
| |
| MI: | 14: 1416 |
| |
| Purity: | ≥98% (HPLC) |
| |
| Identity: | Determined by 1H-NMR and MS. |
| |
| Appearance: | White solid. |
| |
| Solubility: | Soluble in DMSO (50 mg/ml) or 100% ethanol (mg/ml), slightly soluble in water. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Store, as supplied, at -20°C for up to 2 years. Store solutions at -20°C for up to 3 months. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles: S.T. Edmister, et al.; Sci. Rep.
12, 6120 (2022),
Abstract;
Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses: F.S. Varghese, et al.; Antiviral Res.
126, 117 (2016),
Application(s): Cell culture,
Abstract;
Aubner et al.; Neuropsychopharmacol. 216, 88 (1990),
Bromocriptine produces decreases in cocaine self-administration in the rat: C.B. Hubner & G.F. Koob; Neuropsychopharmacol.
3, 101 (1990),
Abstract;
Effect of the dopamine agonist bromocriptine on blood pressure, catecholamines and renin activity in acromegalics at rest, following exercise and during insulin induced hypoglycemia: A. Nilsson & B. Hökfelt; Acta Endocrinol. Suppl. (Copenh.)
216, 83 (1978),
Abstract;
